ClinicalTrials.Veeva

Menu

Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC (ARversusNAR)

U

University of Milan

Status

Unknown

Conditions

Patients Affected by Hepatocellular Carcinoma
Overall Survival
Disease-Free Survival

Treatments

Procedure: anatomical liver resection
Procedure: Non-anatomical liver resection

Study type

Interventional

Funder types

Other

Identifiers

NCT01236989
AR vs NAR

Details and patient eligibility

About

Prognostic impact of AR vs NAR

Full description

Whether anatomical is better than non anatomical resection for HCC is still debated. This prospective randomized study aimed to address which approach is better in terms of patients prognosis.

Enrollment

120 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient affected by single HCC
  • patients in whom liver resection is indicated
  • HCC without vascular invasion and/or thrombosis

Exclusion criteria

  • multinodular HCC
  • metastatic disease
  • spontaneous tumor rupture

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Anatomical resection
Experimental group
Treatment:
Procedure: anatomical liver resection
Non-anatomical resection
Active Comparator group
Treatment:
Procedure: Non-anatomical liver resection

Trial contacts and locations

1

Loading...

Central trial contact

Guido Torzilli, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems